Moderna announced a collaboration to develop a new mRNA therapeutic for Crigler-Najjar Syndrome Type 1 at no cost to patients. Moderna announced in a Sept. 7, 2021, press release a collaboration to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results